Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/2008
08/21/2008US20080200420 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes
08/21/2008US20080200407 Suppress the immunoreactivity of a CpG motif and preventing and treating immune-mediated diseases such as arthritis
08/21/2008US20080200406 Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
08/21/2008US20080200398 Compounds For Enzyme Inhibition
08/21/2008US20080200372 Glycosaminoglycan Peptides Derived From Connective Tissues And Use Thereof In The Prevention Of Arthritis And Other Degenerative Medical Conditions
08/21/2008US20080200368 Peptide composition
08/21/2008US20080199917 Using vector comprising early gene modifications as genetic transfer element in gene therapy; gnentic vaccines
08/21/2008US20080199865 Using allelic variation in interleukin-1RN variable number of tandem repeats as diagnostic/prognostic indicator of decrease cell division and aging characteristics
08/21/2008US20080199508 Containing polyglycan and mucopolysaccharides with polypeptides; improve performance of medical device
08/21/2008US20080199492 Env Polypeptide Complexes and Methods Of Use
08/21/2008US20080199478 Combinations of Immunosupressive Agents for the Treatment or Prevention of Graft Rejections
08/21/2008US20080199466 Activation-inducible lymphocyte immunomediatory molecule specific immunoglobulin for treating and preventing inflammatory, autoimmune, ischemic, transplant and/or allergic disorders
08/21/2008US20080199465 Accelerated lymphocyte homing agent such as fingolimod and one or more compounds selected from an antibody to the IL-2 receptor, an immunosuppressive macrocyclic lactone and a soluble human complement inhibitor
08/21/2008US20080199463 Method for treating multiple myeloma
08/21/2008US20080199454 Caspase inhibitor prodrugs
08/21/2008US20080199445 Compositions and methods for treatment of microbial infections
08/21/2008US20080199435 IL-8 Like Protein
08/21/2008US20080199422 Method for the Treatment of Myelodysplastic Syndromes Using 1-Oxo-2-(2,6-Dioxopiperidin-3-Yl-)-4-Methylisoindoline
08/21/2008US20080199414 Tiliroside or derivative; drugs, foods; ultraviolet radiation filters; aging and oxidation resistance; free radical scavengers; antiinflammatory, anticarcinogenic, and antiallergen agents; plant extracts; topically applied
08/21/2008US20080199405 Polypeptide comprising a soluble Mycobacterium tuberculosis antigen; vaccines
08/21/2008DE202007018403U1 Lutschtablette Lozenge
08/21/2008CA2678427A1 Dual acting prodrugs
08/21/2008CA2678176A1 Sustained delivery formulations of rapamycin compounds
08/21/2008CA2677853A1 Allergen fragments
08/21/2008CA2677748A1 Binding members for ige molecules
08/21/2008CA2677649A1 Bioavailable formulations of heterocyclic compounds
08/21/2008CA2677597A1 Binding members for ige molecules
08/21/2008CA2677397A1 Treatment of inflammatory diseases using placental stem cells
08/21/2008CA2675257A1 Hiv combination vaccine and prime boost method
08/20/2008EP1959013A1 Human circulating virus inhibitory peptide (VRIP) and its use
08/20/2008EP1958966A2 Methods for modulating T cell responses by manipulating a common cytokine receptor gamma chain
08/20/2008EP1958965A2 Agonist antibodies to a musk receptor, and their therapeutic uses
08/20/2008EP1958960A2 A process for the preparation of a non-toxic anthrax vaccine
08/20/2008EP1958935A2 Process for the production of piperidine derivatives with microorganisms
08/20/2008EP1958646A1 Dual carrier immunogenic construct
08/20/2008EP1958645A1 Peptides derived from the major allergen of ragweed (Ambrosia artemisiifolia) and uses thereof
08/20/2008EP1958503A2 Expression of secreted human alpha-fetoprotein in transgenic animals
08/20/2008EP1957491A2 Pyrrolo (2,3-b) pyridine derivatives useful as tec kinase inhibitors
08/20/2008EP1957483A1 Novel vinylogous acids derivatives
08/20/2008EP1957481A1 Pyrrolidin(thi)ones heterocyclically substituted in 3-position
08/20/2008EP1957107A2 Treating inflammatory disorders with antibodies to the alpha-7 nicotinic receptors
08/20/2008EP1957083A1 Beta glycolipids as immuno-modulators
08/20/2008EP1957082A1 Use of high-dose oxazaphosphorine drugs for treating immune disorders
08/20/2008EP1836215B1 Androstane 17-alpha-carbonate for use in the treatment of inflammatory and allergic conditions
08/20/2008EP1732547B1 Anti-hiv quinuclidine compounds
08/20/2008EP1556488B1 Hf-chondroosteomodulin, production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases
08/20/2008EP1509618B1 Autoimmune conditions and nadph oxidase defects
08/20/2008EP1509223B1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin
08/20/2008EP1456203B1 Ethylene diamine derivatives and their use as orexin-receptor antagonists
08/20/2008EP1446500B1 A method for regulating immune function in primates using the foxp3 protein
08/20/2008EP1333850B1 Use of il-13 inhibitors for the treatment of tumors
08/20/2008EP1318993B1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
08/20/2008EP1289993B9 Caspase inhibitors and uses thereof
08/20/2008EP1247103B1 Tethered ligands and methods of use
08/20/2008EP1142473B1 Compositions for acquiring immunological tolerance
08/20/2008EP1075493B1 Dna encoding snorf25 receptor
08/20/2008EP0703897B1 Lipoxin compounds with prolonged half-life
08/20/2008CN101247826A Biodegradable nanoparticle having T-cell recognizable epitope peptide immobilized thereon or encapsulated therein
08/20/2008CN101247800A Anti-allergic agent
08/20/2008CN101245318A Artificial cultivation method of Basidiomycetes and uses thereof
08/20/2008CN101245112A Polyoses extracted from pistacia chinensis meal and extracting method thereof
08/20/2008CN101245097A Inhibitors of serine proteases, particular hcv NS3-NS4 protease
08/20/2008CN101244280A Interfere function of panaxoside Rg1 for self immunity myeloencephalitis mouse
08/20/2008CN101244270A Application of methionine enkephalin in preparing human or animal vaccination
08/20/2008CN101244259A Thymus gland peptide alpha1sustained-release microsphere preparation for injection and preparation thereof
08/20/2008CN101244256A Micro/sub-micro emulsion in situ gel rubber preparation of cyclosporins A for eyes and preparation thereof
08/20/2008CN101244255A Thymus gland pentapeptide injection and uses thereof
08/20/2008CN101244235A Scraping oil, preparation method and application thereof
08/20/2008CN101244163A Tableland yak blood capsule and preparation thereof
08/20/2008CN101244115A Pagodatree flower honey zinc ointment for treating atopic dermatitis
08/20/2008CN101244110A Chinese medicine composition with function of releasing fatigue, reinforcing immunity, and preparation method
08/20/2008CN101244094A Compound preparation for preventing cancer and reinforcing immunity, and preparation method
08/20/2008CN101244093A Method of preparing shiitake fungus polyoses oral liquid
08/20/2008CN101244049A Clenbuterol hydrochloride double-layer sustained release tablets and preparation thereof
08/20/2008CN101244035A Cyclosporins A emulsion preparations for eyes and preparation thereof
08/20/2008CN101243868A Multifunctional health care instant tea and its preparing process
08/20/2008CN101243865A Corn chips for nourishing hardiness
08/20/2008CN101243814A Milk powder for the old and preparation thereof
08/20/2008CN101243806A Pseudo-ginseng bread
08/20/2008CN101243805A Health care biscuit
08/20/2008CN100412090C Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
08/20/2008CN100412087C Sequence number2 bioactive peptide
08/20/2008CN100412073C Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
08/20/2008CN100411620C Use of dipyridazole or mopidamol in the manufacture of a medicament for treatment and prevention of fibrin-dependent microcirculation disorders
08/20/2008CN100411617C Use of flavone compounds in preparing medicament
08/20/2008CN100411609C Nano-emulsion drug of triperygium wilfordii polycoride and preparation method thereof
08/19/2008US7414122 host cell, viral vector; agonists and antagonists; diagnosis or treatment of cancer; antiproliferative; infertility, miscarriage, preterm labor and delivery, and endometriosis; immunosuppressants; vaccine adjuvants; genetic mapping
08/19/2008US7414120 enhances ubiquitination of phosphorylated I kappa B; human E3 ubiquitin ligase polypeptides; inflammatory diseases, autoimmune diseases, cancer and viral infections
08/19/2008US7414073 Baccatin III analog conjugated to cell binding agent such as monoclonal antibody through a link from the oxygen atom at the C-7 position; treating cancer, rheumatoid arthritis, transplant rejection, viral and parasite infections
08/19/2008US7414054 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
08/19/2008US7414048 4,5-dihydro-isoxazole derivatives and their pharmaceutical use
08/19/2008US7414047 Piperazinyl and diazapanyl benzamides and benzthioamides
08/19/2008US7414026 Inhibitors of NF-kappaB activation
08/19/2008US7414024 B-cell differentiation factor (il-6); anticancer agents; antisense agents; monoclonal antibody
08/19/2008US7413756 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
08/19/2008US7413736 Administering anti-idiotype antibody or antibody fragment comprising heavy chain variable region sequences and light chain variable region sequences conjugated to a soluble immunogenic carrier protein
08/19/2008CA2461567C Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
08/19/2008CA2432799C Pyrazole compounds useful as protein kinase inhibitors
08/19/2008CA2318372C A universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use
08/19/2008CA2268399C Anti-neurogenic inflammatory compounds and compositions and methods of use thereof
1 ... 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 ... 1172